BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 16034807)

  • 1. Cancer surveillance in ulcerative colitis.
    Chambers WM; Warren BF; Jewell DP; Mortensen NJ
    Br J Surg; 2005 Aug; 92(8):928-36. PubMed ID: 16034807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk of colorectal cancer in ulcerative colitis--monitoring strategies and identification of risk patients].
    Porschen R; Strohmeyer G
    Z Gastroenterol; 1992 Sep; 30(9):585-93. PubMed ID: 1449007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pathogenesis of ulcerative colitis-associated colorectal cancer].
    Sipos J
    Magy Onkol; 2004; 48(1):35-43. PubMed ID: 15105894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer biology in ulcerative colitis and potential use in endoscopic surveillance.
    Shapiro BD; Lashner BA
    Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):453-68. PubMed ID: 9177146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: colorectal carcinoma and inflammatory bowel disease.
    Eaden J
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():24-30. PubMed ID: 15352890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysplasia in inflammatory bowel disease.
    Greenson JK
    Semin Diagn Pathol; 2002 Feb; 19(1):31-7. PubMed ID: 11936264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis.
    Thomas T; Abrams KA; Robinson RJ; Mayberry JF
    Aliment Pharmacol Ther; 2007 Mar; 25(6):657-68. PubMed ID: 17311598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
    Lindberg J; Stenling R; Palmqvist R; Rutegård J
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The malignant side of chronic inflammatory bowel disease].
    West RL; van de Vrie W; Schouten WR; van Dekken H; Kuipers EJ
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2521-4. PubMed ID: 12532661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study.
    Velayos FS; Loftus EV; Jess T; Harmsen WS; Bida J; Zinsmeister AR; Tremaine WJ; Sandborn WJ
    Gastroenterology; 2006 Jun; 130(7):1941-9. PubMed ID: 16762617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer surveillance in ulcerative colitis: a survey of patients' knowledge.
    Robinson RJ; Hart AR; Mayberry JF
    Endoscopy; 1996 Nov; 28(9):761-2. PubMed ID: 9007430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: colorectal cancer surveillance in ulcerative colitis - what should we be doing?
    Obrador A; Ginard D; Barranco L
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():56-63. PubMed ID: 16961747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
    Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
    Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study.
    Terg R; Sambuelli A; Coronel E; Mazzuco J; Cartier M; Negreira S; Muñoz A; Gil A; Miguez C; Huernos S; Romero G; Goncalvez S; Levi D; Abecasis R
    Acta Gastroenterol Latinoam; 2008 Mar; 38(1):26-33. PubMed ID: 18533354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of patients with chronic ulcerative colitis. WHO Collaborating Centre for the Prevention of Colorectal Cancer.
    Levin B; Lennard-Jones J; Riddell RH; Sachar D; Winawer SJ
    Bull World Health Organ; 1991; 69(1):121-6. PubMed ID: 1905205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA aneuploidy as a marker of premalignancy in surveillance of patients with ulcerative colitis.
    Lindberg JO; Stenling RB; Rutegård JN
    Br J Surg; 1999 Jul; 86(7):947-50. PubMed ID: 10417571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand.
    Gearry RB; Wakeman CJ; Barclay ML; Chapman BA; Collett JA; Burt MJ; Frizelle FA
    Dis Colon Rectum; 2004 Mar; 47(3):314-22. PubMed ID: 14991493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.